Name of the medicinal product: Influvac sub-unit Tetra
Influenza virus surface antigens (inactivated) (haemagglutinin and neuraminidase) of the following strains*:
- A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215) 15 micrograms HA ** per 0.5 ml dose
- A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010) 15 micrograms HA ** per 0.5 ml dose
- B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) 15 micrograms HA ** per 0.5 ml dose
- B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA ** per 0.5 ml dose
* propagated in fertilised hens' eggs from healthy chicken flocks
** haemagglutinin.
This vaccine complies with the World Health Organisation (WHO) recommendation (northern hemisphere) and EU recommendation for the 2022/2023 season.